Sangamo Therapeutics, Inc SEC filings SGMOQ
Sangamo Therapeutics, Inc has 1,000 filings in SEC EDGAR's recent list, going back to Feb 5, 2013. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on May 14, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Oct 27, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 16, 2026 | Oct 14, 2026 |
| 25-NSE | Delisting notice | Oct 7, 2026 | — |
| 8-K |
Current report
Bankruptcy, Acquisition or sale of assets
|
Sep 21, 2026 | Sep 17, 2026 |
| 8-K |
Current report
Bankruptcy, Acquisition or sale of assets, Regulation FD disclosure
|
Sep 8, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Material agreement, Bankruptcy
|
Aug 28, 2026 | Aug 25, 2026 |
| NT 10-Q | Filing | Aug 17, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 13, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 12, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Bankruptcy, Listing notice
|
Jul 20, 2026 | Jul 14, 2026 |
| 8-K |
Current report
Auditor change, Other events
|
Jul 1, 2026 | Jun 24, 2026 |
| 8-K/A | Amended current report | Jun 23, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Material agreement, Bankruptcy, New debt, Exit or restructuring costs
|
Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 25, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 25, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 25, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 25, 2026 |
| 4 | Insider transaction | May 27, 2026 | May 25, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Listing notice
|
Apr 29, 2026 | Apr 28, 2026 |
| 4 | Insider transaction | Apr 23, 2026 | Apr 22, 2026 |
| 4 | Insider transaction | Apr 23, 2026 | Apr 21, 2026 |
| 144 | Notice of proposed sale | Apr 22, 2026 | — |
| 144 | Notice of proposed sale | Apr 6, 2026 | — |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2026 | Mar 30, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 24, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 24, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 24, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 24, 2026 |
| 4 | Insider transaction | Feb 26, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Feb 4, 2026 | Feb 3, 2026 |
| 424B5 | Prospectus supplement | Feb 4, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 3, 2026 | Feb 3, 2026 |
| FWP | Free writing prospectus | Feb 3, 2026 | — |
| 8-K |
Current report
Results of operations, Officer or director change
|
Feb 3, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Jan 26, 2026 | Jan 22, 2026 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 26, 2025 | Nov 24, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Listing notice
|
Oct 29, 2025 | Oct 29, 2025 |
| 4 | Insider transaction | Oct 24, 2025 | Oct 22, 2025 |
| 4 | Insider transaction | Oct 24, 2025 | Oct 22, 2025 |
| 4 | Insider transaction | Oct 24, 2025 | Oct 22, 2025 |
| 4 | Insider transaction | Oct 24, 2025 | Oct 22, 2025 |
| 4 | Insider transaction | Oct 24, 2025 | Oct 22, 2025 |
| 4 | Insider transaction | Oct 24, 2025 | Oct 22, 2025 |
| 3 | Initial insider ownership | Oct 9, 2025 | Oct 1, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2025 | Sep 9, 2025 |
| 8-K |
Current report
Other events
|
Sep 4, 2025 | Sep 4, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 24, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 24, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 24, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 24, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 24, 2025 |
| S-8 | Employee stock plan registration | Aug 8, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 4 | Insider transaction | Jul 24, 2025 | Jul 22, 2025 |
| 8-K |
Current report
Other events
|
Jun 24, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 24, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 24, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 24, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 24, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 24, 2025 |
| 424B5 | Prospectus supplement | May 13, 2025 | — |
| 8-K |
Current report
Other events
|
May 13, 2025 | May 12, 2025 |
| FWP | Free writing prospectus | May 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Listing notice
|
May 6, 2025 | Apr 30, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | Apr 24, 2025 | Apr 22, 2025 |
| 4 | Insider transaction | Apr 24, 2025 | Apr 22, 2025 |
| 4 | Insider transaction | Apr 24, 2025 | Apr 22, 2025 |
| 4 | Insider transaction | Apr 24, 2025 | Apr 22, 2025 |
| 4 | Insider transaction | Apr 24, 2025 | Apr 22, 2025 |
| 10-K | Annual report | Mar 17, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 24, 2025 |
| 8-K |
Current report
Other events
|
Feb 6, 2025 | Feb 6, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| 4 | Insider transaction | Jan 24, 2025 | Jan 22, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 7, 2025 | — |
| 8-K |
Current report
Agreement ended
|
Dec 30, 2024 | Dec 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 24, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 24, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 24, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 24, 2024 |
| 4 | Insider transaction | Nov 26, 2024 | Nov 24, 2024 |
| EFFECT | Filing | Nov 19, 2024 | — |
| CORRESP | Letter to the SEC | Nov 18, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2024 | — |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| S-3 | Shelf registration | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| 3 | Initial insider ownership | Oct 28, 2024 | Oct 18, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 4, 2024 | Oct 4, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 24, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 24, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 24, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 24, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 24, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 16, 2024 | — |
| 4 | Insider transaction | Aug 15, 2024 | Aug 13, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Other events
|
Jul 24, 2024 | Jul 24, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jul 8, 2024 | — |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Jun 6, 2024 | Jun 4, 2024 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 5, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 24, 2024 |
| 4 | Insider transaction | May 29, 2024 | May 24, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Listing notice
|
Apr 30, 2024 | Apr 24, 2024 |
| ARS | Annual report to shareholders | Apr 19, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 19, 2024 | Jun 4, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Apr 5, 2024 | — |
| PRE 14A | Preliminary proxy statement | Apr 3, 2024 | Jun 4, 2024 |
| 8-K |
Current report
Other events
|
Mar 25, 2024 | Mar 21, 2024 |
| 424B5 | Prospectus supplement | Mar 25, 2024 | — |
| 8-K |
Current report
Results of operations
|
Mar 13, 2024 | Mar 13, 2024 |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| 4 | Insider transaction | Feb 27, 2024 | Feb 24, 2024 |
| 4 | Insider transaction | Feb 27, 2024 | Feb 24, 2024 |
| 4 | Insider transaction | Feb 27, 2024 | Feb 24, 2024 |
| 4 | Insider transaction | Feb 27, 2024 | Feb 24, 2024 |
| 4 | Insider transaction | Feb 27, 2024 | Feb 24, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 6, 2024 | Feb 5, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 26, 2024 | — |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| 4 | Insider transaction | Jan 24, 2024 | Jan 22, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 22, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Jan 19, 2024 | Jan 19, 2024 |
| 8-K |
Current report
Other events
|
Dec 13, 2023 | Dec 11, 2023 |
| 4 | Insider transaction | Nov 28, 2023 | Nov 25, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- SGMOQ (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Richmond, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1001233
- Former names
- SANGAMO BIOSCIENCES INC (until Jan 6, 2017)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.